Urgent Needs to Consider and Assess the Transmission of Coronavirus (COVID-19) via Hospital Sewage and Wastewater
Full Text (PDF)
Laila Mandi 1 2 *
More Detail
1 National Center for Studies and Research on Water and Energy (CNEREE), Cadi Ayyad University, P.O. Box. 511, Marrakech, Morocco
2 Water, Biodiversity and Climate Change Laboratory, Faculty of Sciences Semlalia, P.O.Box: 2390 Marrakech, Morocco
* Corresponding Author

Abstract

The emergence and spread of SARS-CoV-2 responsible for COVID-19 disease are considered as a major threat to human health since WHO declared COVID-19 outbreak a global pandemic. In recent studies, scientists confirmed the presence of SARS-CoV-2 RNA in feces of COVID-19 patients and wastewater. In several areas, particularly low-income countries, hospital effluents are not disinfected or pretreated and they are mostly discharged into urban sewerage systems reaching wastewater treatment plants depending if it exists or not, consequently several infectious agents could be developed such as Coronavirus COVID-19 causing significant environmental and health risks. Several researchers across the world suggested that wastewater surveillance could be a sensitive tool to monitor the circulation of the virus in the population and may represent a complementary approach to measure the presence and the prevalence of current infectious disease when the capacity for clinical testing is limited. Only a few studies were done on the survival of Coronaviruses in wastewater and still there is limited information on its transmission potential through the environment. Taking into account the current situation, there is an urgent need to consider and assess the transmission of Coronavirus (COVID-19) via hospital sewage and wastewater. Further researches are imperative to fill the knowledge gaps in COVID-19 behavior in hospital and urban sewage, and wastewater treatment plants, identify the safety measures and better manage the pandemic phenomena.

Keywords

License

This is an open access article distributed under the Creative Commons Attribution License (CC BY 4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Letter to Editor

https://doi.org/10.5799/jcei/8261

J Clin Exp Invest, 2020 - Volume 11 Issue 3, Article No: em00745

Publication date: 11 May 2020

Article Views: 1769

Article Downloads: 532

Open Access References How to cite this article